Answers are grounded in this paper and cite their sources.
The association of biomarker expression with survival varies substantially between subtypes, and can easily be overlooked in whole cohort analyses. To avoid this effect, each subtype within a cohort should be analyzed discretely. Ovarian carcinoma subtypes are different diseases, and these differences should be reflected in clinical research study design and ultimately in the management of ovarian carcinoma.
No takes yet. Share an insight, caveat, or question.
Köbel et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: